Clinical Trial Update: A Clinical Trial of Intravenous (IV) Ganaxolone in Women With Postpartum Depression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of intravenous ganaxolone in women with postpartum depression has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder
• Major Depressive Disorder
• Postpartum Depression

Drugs mentioned

• ganaxolone (ganaxolone)

Snippet

Sponsor: Marinus Pharmaceuticals | Conditions: Depression, Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2023-02-08